Chronic Lymphocytic Leukemia (CLL)

Showing NaN - NaN of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL) Trial in United States (voruciclib

Recruiting
  • Follicular Lymphoma (FL)
  • +6 more
  • voruciclib monotherapy
  • voruciclib and venetoclax
  • Duarte, California
  • +10 more
Aug 10, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM) Trial in United States

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Duarte, California
  • +10 more
Jul 14, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Venetoclax monotherapy, Venetoclax

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Venetoclax monotherapy
  • Venetoclax with anti CD20 monoclonal antibody
  • Basking Ridge, New Jersey
  • +9 more
Mar 15, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL) Trial in Switzerland, United

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Tucson, Arizona
  • +23 more
Dec 14, 2021

Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) Trial in United States (TRU-016 (anti-CD37 protein

Completed
  • Chronic Lymphocytic Leukemia (CLL)
  • Non-Hodgkin's Lymphoma (NHL)
  • TRU-016 (anti-CD37 protein therapeutic)
  • Birmingham, Alabama
  • +6 more
Jun 26, 2017